ARWR
Arrowhead Pharmaceuticals Inc.
Halal Rating :
Last Price
$19.56
Last updated:
Market Cap
-
7D Change
3.44%
1 Year Change
-41.07%
Company Overview
Industries
Exchange
Next Earnings Date
Arrowhead Pharmaceuticals Inc. develops medicines that treat diseases with a genetic basis using its platform technologies. The company focuses on developing RNA interference (RNAi) therapeutics that selectively block the production of disease-causing proteins. Their pipeline includes treatments for various diseases including cardiovascular disease, liver disease, and cancer.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Arrowhead Pharmaceuticals Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.